Global Gene Editing Market to Grow at Over 14% CAGR from 2016 to 2024
Recombinetics is listed as a "major industry participant" in this report on Global Gene Editing Market by Global Market Insights.
Recombinetics Expands Its Scientific Advisory Board
Recombinetics Expands Its Scientific Advisory Board Roster features distinguished leaders in academia and biotechnology Today, Recombinetics announced the expansion of its Scientific Advisory Board, led by Recombinetics’ co-founder and Board Director, Dr. Perry Hackett. The advisory board consists of renowned leaders in academia and biotechnology who will bring valuable insights [...]
Recombinetics Awarded Two NIH Grants to Develop Humanized Swine Models of Alzheimer’s Disease and Neurofibromatosis 2
Recombinetics announces the receipt of two Small Business Innovative Research (SBIR) grant awards from the National Institutes of Health totaling more than $700,000. The first grant from the National Institute on Aging is to develop a genetically accurate swine model of Alzheimer’s disease. The second grant from the National Institute [...]
Recombinetics Awarded NIH Grant to Develop a Humanized Swine Model of Alzheimer’s Disease
ST. PAUL, MINNESOTA – Recombinetics, a global biotechnology leader in gene editing of livestock for human therapeutics and food production applications, has been awarded a $358,338 Phase I Small Business Innovative Research (SBIR) grant from the National Institute on Aging, National Institutes of Health (NIH) to create a genetically accurate [...]
Recombinetics Named Finalist for Minnesota High Tech Association Tekne Awards
Gene-Editing Leader Recognized for Achievement in Agriculture Technology with Polled Cattle Recombinetics joins Minnesota’s top technology companies as a finalist for this year’s Tekne Awards. The Minnesota High Tech Association-sponsored awards feature innovative leadership and technology in Minnesota. Recombinetics is one of three finalists in the Agriculture Technology and Food [...]
Recombinetics Expands Senior Management Team with Industry Veterans in Agriculture and Biomedicine
Gene-editing leader adds top talent to commercialize rapid growth business lines ST. PAUL, MN. Recombinetics (Recombinetics.com), a St. Paul-based global leader in gene-editing of livestock for food production and human therapeutic applications, is pleased to announce the hiring of Tom Erdmann as General Manager of its agriculture business Acceligen (Acceligen.com), and [...]
Recombinetics Introduces New Executive Suite and Board of Directors
ST. PAUL, MN. – Recombinetics (recombinetics.com), a St. Paul-based gene-editing company, has hired Ian R. Friendly as Chief Executive Officer and Tammy Lee Stanoch as Chief Corporate Affairs Officer. The company’s previous CEO and founder, Dr. Scott Fahrenkrug, has been elevated to Executive Chairman of the Board and will also [...]
Leading Scientists Assert GRAS Status for Gene-Edited Livestock Gene-edited livestock is safe for human consumption; Pre-market approval by the FDA should not be required
ST. PAUL, MN – In a communication published in this month’s prestigious Nature Biotechnology journal, Recombinetics, a St. Paul-based gene-editing company founded by Chief Executive Officer and Chairman of the Board Scott Fahrenkrug, Ph.D., reported the precise genetic dehorning of dairy cattle using TALENs, without any off-target effects. Physical dehorning of cattle, [...]